626 patients were included in this study, 313 in each study arm (WLC versus BLC). Outcomes data for BRAVO was measured at a 3-year time point in a predominately high-risk patient population.
Hosted on MSN1mon
Bastide le Confort Medical Reports Strong First-Half Growth and Confirms Targets for 2024-2025Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover ... Smart Portfolio Bastide le Confort Medical ( (FR:BLC)) just unveiled an update. Bastide le Confort Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback